Decreased needs for hospital care and antibiotics in children with advanced HIV-1 disease after protease inhibitor-containing combination therapy

被引：13
|
作者：
Canani, RB [1 ]
Spagnuolo, MI [1 ]
Cirillo, P [1 ]
Guarino, A [1 ]
机构：
[1] Univ Naples Federico II, Dept Pediat, Naples, Italy
来源：
AIDS | 1999年 / 13卷 / 08期
关键词：
D O I：
10.1097/00002030-199905280-00026
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1005 / 1006
页数：2
相关论文
共 37 条
  • [1] Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen
    Valdez, H
    Smith, KY
    Landay, A
    Connick, E
    Kuritzkes, DR
    Kessler, H
    Fox, L
    Spritzler, J
    Roe, J
    Lederman, MB
    Lederman, HM
    Evans, TG
    Heath-Chiozzi, M
    Lederman, MM
    AIDS, 2000, 14 (01) : 11 - 21
  • [2] Impact of protease inhibitor-containing combination antiretroviral therapies on height and weight growth in HIV-infected children
    Buchacz, K
    Cervia, JS
    Lindsey, JC
    Hughes, MD
    Seage, GR
    Dankner, WM
    Oleske, JM
    Moye, J
    PEDIATRICS, 2001, 108 (04) : E72
  • [3] Efficient Suppression of Minority Drug-Resistant HIV Type 1 (HIV-1) Variants Present at Primary HIV-1 Infection by Ritonavir-Boosted Protease Inhibitor-Containing Antiretroviral Therapy
    Metzner, Karin J.
    Rauch, Pia
    von Wyl, Viktor
    Leemann, Christine
    Grube, Christina
    Kuster, Herbert
    Boeni, Juerg
    Weber, Rainer
    Guenthard, Huldrych F.
    JOURNAL OF INFECTIOUS DISEASES, 2010, 201 (07): : 1063 - 1071
  • [4] Protease inhibitor-containing regimens compared with nucleoside analogues alone in the suppression of persistent HIV-1 replication in lymphoid tissue
    Ruiz, L
    van Lunzen, J
    Arno, A
    Stellbrink, HJ
    Schneider, C
    Rull, M
    Castellà, E
    Ojanguren, I
    Richman, DD
    Clotet, B
    Tenner-Racz, K
    AIDS, 1999, 13 (01) : F1 - F8
  • [5] Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease
    Race, EM
    Adelson-Mitty, J
    Kriegel, GR
    Barlam, TF
    Reimann, KA
    Letvin, NL
    Japour, AJ
    LANCET, 1998, 351 (9098): : 252 - 255
  • [6] Hypofibrinolytic state in HIV-1-infected patients treated with protease inhibitor-containing highly active antiretroviral therapy
    Koppel, K
    Bratt, G
    Schulman, S
    Bylund, H
    Sandström, E
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 29 (05) : 441 - 449
  • [7] Protease inhibitor combination therapy, severity of illness, and quality of life among children with perinatally acquired HIV-1 infection
    Storm, DS
    Boland, MG
    Gortmaker, SL
    He, Y
    Skurnick, J
    Howland, L
    Oleske, JM
    PEDIATRICS, 2005, 115 (02) : E173 - E182
  • [8] Activity of combination abacavir/amprenavir/efavirenz therapy in HIV-1 infected subjects failing their current protease inhibitor containing regimen
    Eron, J
    Falloon, J
    Masur, H
    Ait-Khaled, M
    Thomas, D
    Manion, D
    Rogers, M
    AIDS, 1998, 12 : S13 - S13
  • [9] Do protease inhibitor-containing combination antiretroviral therapy regimens increase risk of spontaneous preterm birth in pregnant HIV-Positive women?
    Pakzad, Z.
    Wagner, E. C.
    Chaworth-Musters, T.
    Berg, K.
    Albert, A. Y. K.
    van Schalkwyk, J.
    Maan, E.
    Azampanah, A.
    McClymont, E.
    Alimenti, A.
    Forbes, J.
    Money, D.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2017, 217 (06) : 716 - 716
  • [10] The impact of protease inhibitor-containing highly active antiretroviral therapy on progression of HIV disease and its relationship to CD4 and viral load
    Miller, V
    Sabin, CA
    Phillips, AN
    Rottmann, C
    Rabenau, H
    Weidmann, E
    Rickerts, V
    Findhammer, S
    Helm, EB
    Staszewski, S
    AIDS, 2000, 14 (14) : 2129 - 2136
1234